Eloxx Pharmaceuticals, Inc. (ELOX) stock
ELOXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$11.74−1.01 (-7.92%)
Close on Nov 17, 2026Market cap $79.70MP/E –Yield –
Eloxx Pharmaceuticals price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Eloxx Pharmaceuticals's price to book ratio was 1.1× on Nov 11, 2026, against 24.5× a year earlier. Over the last 5 years it ranged from 1.1× to 382.7×, with a median of 57.0×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 1.1× | −8.0 |
| 2023 | Jul 31, 2023 | 9.1× | −66.7 |
| 2022 | Oct 31, 2022 | 75.9× | +55.4 |
| 2021 | Dec 31, 2021 | 20.4× | −96.2 |
| 2020 | Dec 31, 2020 | 116.6× | +45.0 |
| 2019 | Dec 31, 2019 | 71.6× | −18.6 |
| 2018 | Dec 31, 2018 | 90.2× | −305.3 |
| 2017 | Dec 29, 2017 | 395.5× | – |
See a number that looks wrong?